[HTML][HTML] Pharmaceutical treatment of osteoarthritis

MJ Richard, JB Driban, TE McAlindon - Osteoarthritis and Cartilage, 2023 - Elsevier
Objective To review the current state of pharmaceutical treatment recommendations for the
management of osteoarthritis. Method A narrative review was drafted to describe treatment …

[HTML][HTML] An overview of tramadol and its usage in pain management and future perspective

M Subedi, S Bajaj, MS Kumar, YC Mayur - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Patients with chronic non-malignant pain report impairment of physical and social life along
with psychological state affecting their overall quality of life. The purpose of managing pain …

[HTML][HTML] The mechanisms involved in morphine addiction: an overview

J Listos, M Łupina, S Talarek, A Mazur… - International journal of …, 2019 - mdpi.com
Opioid use disorder is classified as a chronic recurrent disease of the central nervous
system (CNS) which leads to personality disorders, co-morbidities and premature death. It …

[HTML][HTML] Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies

S Franchi, G Moschetti, G Amodeo… - Frontiers in …, 2019 - frontiersin.org
Suppression of the immune system has been constantly reported in the last years as a
classical side effect of opioid drugs. Most of the studies on the immunological properties of …

[HTML][HTML] Full opioid agonists and tramadol: pharmacological and clinical considerations

AN Edinoff, LA Kaplan, S Khan… - … and Pain Medicine, 2021 - ncbi.nlm.nih.gov
Opioids are mu receptor agonists and have been an important part of pain treatment for
thousands of years. In order to use these drugs appropriately and successfully in patients …

[HTML][HTML] Hot topics in opioid pharmacology: mixed and biased opioids

AAH Azzam, J McDonald, DG Lambert - British journal of anaesthesia, 2019 - Elsevier
Analgesic design and evaluation have been driven by the desire to create high-affinity high-
selectivity mu (μ)-opioid peptide (MOP) receptor agonists. Such ligands are the mainstay of …

Direct synthesis of cycloalkanes from diols and secondary alcohols or ketones using a homogeneous manganese catalyst

A Kaithal, LL Gracia, C Camp… - Journal of the …, 2019 - ACS Publications
A method for the synthesis of substituted cycloalkanes was developed using diols and
secondary alcohols or ketones via a cascade hydrogen borrowing sequence. A non-noble …

[HTML][HTML] High prevalence of cannabidiol use within male professional rugby union and league players: a quest for pain relief and enhanced recovery

AM Kasper, SA Sparks, M Hooks… - … journal of sport …, 2020 - journals.humankinetics.com
Rugby is characterized by frequent high-intensity collisions, resulting in muscle soreness.
Players consequently seek strategies to reduce soreness and accelerate recovery, with an …

A Phosphine-Free Manganese Catalyst Enables Stereoselective Synthesis of (1 + n)-Membered Cycloalkanes from Methyl Ketones and 1,n-Diols

A Jana, K Das, A Kundu, PR Thorve, D Adhikari… - ACS …, 2020 - ACS Publications
Herein, we report the stereoselective synthesis of (1+ n)-membered cycloalkane from methyl
ketone and 1, n-diol. A manganese (I) complex bearing a phosphine-free ligand catalyzed …

Revisiting tramadol: a multi-modal agent for pain management

A Barakat - CNS drugs, 2019 - Springer
Tramadol—an atypical opioid analgesic—has a unique pharmacokinetic and
pharmacodynamic profile, with opioidergic, noradrenergic, and serotonergic actions …